Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia [PDF]
Chronic myelomonocytic leukemia is a heterogeneous disease with multifactorial molecular pathogenesis. Various recurrent somatic mutations have been detected alone or in combination in chronic myelomonocytic leukemia.
Sarah Abu Kar +17 more
doaj +3 more sources
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups [PDF]
With the aim of reviewing critical concepts and producing recommendations for the management of chronic myelomonocytic leukemia, key questions were selected according to the criterion of clinical relevance.
Francesco Onida +7 more
doaj +2 more sources
Donor cell leukemia is a very rare cause of relapse after allogeneic hematopoietic cell transplantation (alloHCT). Herein, we describe an unprecedented case of donor cell‐derived chronic myelomonocytic leukemia (CMML) presenting seven years after a 51 ...
Kevin C. Miller +3 more
doaj +2 more sources
Chronic myeloid leukemia (CML) and chronic myelomonocytic leukemia (CMML) are two common myeloid neoplasms with overlapping morphologic features. We report a patient initially diagnosed with CML and treated with Tyrosine kinase inhibitor (TKI) but who ...
Jinming Song +3 more
doaj +2 more sources
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts [PDF]
Chronic myelomonocytic leukemia is similar to but a separate entity from both myeloproliferative neoplasms and myelodysplastic syndromes, and shows either myeloproliferative or myelodysplastic features.
Véronique Gelsi-Boyer +11 more
doaj +2 more sources
Successful Treatment of Leukemic Synovitis Complicated With Chronic Myelomonocytic Leukemia [PDF]
Chronic myelomonocytic leukemia (CMML) is a myeloproliferative disease characterized by monocyte-predominant hematopoiesis. It is sometimes complicated with cutaneous involvement known as leukemic cutis, which is associated with a poor prognosis.
Hiroki Tsutsumi +8 more
doaj +2 more sources
Molecular devolution in chronic myelomonocytic leukemia during treatment with decitabine/cedazuridine: A case report [PDF]
Oral decitabine/cedazuridine has been studied in chronic myelomonocytic leukemia (CMML) recently but the molecular changes during this treatment have not been reported so far. We report a CMML patient who was treated with oral decitabine/cedazuridine and
Klaus Geissler +2 more
doaj +2 more sources
Cerebral localization of chronic myelomonocytic leukemia: a case report
Background Chronic myelomonocytic leukemia is a myelodysplastic/myeloproliferative neoplasm characterized by the infiltration of blood and bone marrow by immature monocytes.
Clémence Haméon +7 more
doaj +1 more source
Spontaneous splenic rupture – An uncommon complication of chronic myelomonocytic leukemia
Chronic Myelomonocytic Leukemia (CMML) is a blood malignancy that presents with splenomegaly in up to 40% of the patients; however, a pathological splenic rupture is very rare.
Abdul Muqtadir Abbasi +2 more
doaj +1 more source
Prior studies have investigated patients' characteristics, treatments, and outcomes for older adults with myelodysplastic syndromes, but most failed to distinguish chronic myelomonocytic leukemia. Recognizing potentially important differences between the
Dan P. Zandberg +6 more
doaj +1 more source

